Global DNA Sequencing

DNA Sequencing Comprehensive Study by Type (Instruments, Consumables, Services), Application (Clinical Investigation, Oncology, Forensics & Agrigenomics, Reproductive Health, HLA Typing, Others), Technology (Third Generation DNA Sequencing, Next-Generation Sequencing, Sanger Sequencing), End User (Clinical Research, Academic Research, Biotechnology & Pharmaceutical Companies, Hospitals & Clinics, Others) Players and Region - Global Market Outlook to 2032

DNA Sequencing Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About DNA Sequencing
DNA sequencing is important to apply to the human genome. It allows scientists to sequence genes and genomes. DNA Sequencing market is expected to grow in the future due to the rising demand for easy and fast clinical diagnosis and an increase in cancer research activities. The surging trend of personalized genomics boosting the market. The fast development of DNA sequencing technology is providing scientists with the capability to generate information about genetic variation and outlines of gene expression on an unparalleled scale. The DNA sequencing technology is expected to allow scientists in achieving accurate sequencing of whole human genomes within just a few years. This technology will become a routine tool for scientists and clinicians. Numerous sequencing platforms presently in development have the potential to present greater advances in resolution and throughput. The massively parallel sequencing technologies are at present altering almost all fields of genetics, and the field of pharmacogenomics will be no exemption. The most predominant application of the new sequencing technologies in the field of pharmacogenomics is the detection of novel genetic variations that might influence drug response.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)


The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global DNA Sequencing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Siemens AG (Germany), Pacific Biosciences of California, Inc. (United States), Eppendorf (Germany), PerkinElmer, Inc. (United States), Agilent Technologies, Inc. (United States), Illumina, Inc. (United States), LI-COR Biosciences, Inc (United States), Oxford Nanopore Technologies Limited (United Kingdom), F. Hoffmann-La Roche AG (Switzerland), ThermoFisher Scientific (United States) and Longas Technologies (Australia) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are QIAGEN (Germany), Macrogen, Inc. (South Korea), Bio-Rad Laboratories, Inc. (United States) and Myriad Genetics (United States).

Segmentation Overview
AMA Research has segmented the market of Global DNA Sequencing market by Type (Instruments, Consumables and Services), Application (Clinical Investigation, Oncology, Forensics & Agrigenomics, Reproductive Health, HLA Typing and Others) and Region.



On the basis of geography, the market of DNA Sequencing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Third Generation DNA Sequencing will boost the DNA Sequencing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Clinical Research will boost the DNA Sequencing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising demand for precision medicine

Market Growth Drivers:
Growing Demand for Easy and Fast Clinical Diagnosis and Increasing Number of Genome Mapping Programs

Challenges:
Dearth of Skilled Professionals

Restraints:
Expensive Machinery

Opportunities:
Increasing prevalence of cancer and Technological advances in next-generation sequencing technologies

Market Leaders and their expansionary development strategies
In August 2024, Illumina partnered with the Broad Institute to develop new gene sequencing kits utilizing CRISPR technology. This collaboration aims to scale up gene sequencing volumes, potentially advancing disease and treatment research.
In October 2024, Illumina introduced the MiSeq i100 and MiSeq i100 Plus Systems, compact and affordable benchtop sequencers designed to make next-generation sequencing more accessible to a broader range of laboratories. These devices offer rapid sequencing capabilities with results available in as little as four hours


Key Target Audience
Manufacturers, Research laboratories and academic institutes, Venture capitalists, Research and consulting firms, Pharmaceutical and biotechnology companies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Instruments
  • Consumables
  • Services
By Application
  • Clinical Investigation
  • Oncology
  • Forensics & Agrigenomics
  • Reproductive Health
  • HLA Typing
  • Others
By Technology
  • Third Generation DNA Sequencing
  • Next-Generation Sequencing
  • Sanger Sequencing

By End User
  • Clinical Research
  • Academic Research
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Easy and Fast Clinical Diagnosis
      • 3.2.2. Increasing Number of Genome Mapping Programs
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Rising demand for precision medicine
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global DNA Sequencing, by Type, Application, Technology, End User and Region (value) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global DNA Sequencing (Value)
      • 5.2.1. Global DNA Sequencing by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Consumables
        • 5.2.1.3. Services
      • 5.2.2. Global DNA Sequencing by: Application (Value)
        • 5.2.2.1. Clinical Investigation
        • 5.2.2.2. Oncology
        • 5.2.2.3. Forensics & Agrigenomics
        • 5.2.2.4. Reproductive Health
        • 5.2.2.5. HLA Typing
        • 5.2.2.6. Others
      • 5.2.3. Global DNA Sequencing by: Technology (Value)
        • 5.2.3.1. Third Generation DNA Sequencing
        • 5.2.3.2. Next-Generation Sequencing
        • 5.2.3.3. Sanger Sequencing
      • 5.2.4. Global DNA Sequencing by: End User (Value)
        • 5.2.4.1. Clinical Research
        • 5.2.4.2. Academic Research
        • 5.2.4.3. Biotechnology & Pharmaceutical Companies
        • 5.2.4.4. Hospitals & Clinics
        • 5.2.4.5. Others
      • 5.2.5. Global DNA Sequencing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. DNA Sequencing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Siemens AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pacific Biosciences of California, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Eppendorf (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. PerkinElmer, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Agilent Technologies, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Illumina, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. LI-COR Biosciences, Inc (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Oxford Nanopore Technologies Limited (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ThermoFisher Scientific (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Longas Technologies (Australia)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global DNA Sequencing Sale, by Type, Application, Technology, End User and Region (value) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global DNA Sequencing (Value)
      • 7.2.1. Global DNA Sequencing by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Consumables
        • 7.2.1.3. Services
      • 7.2.2. Global DNA Sequencing by: Application (Value)
        • 7.2.2.1. Clinical Investigation
        • 7.2.2.2. Oncology
        • 7.2.2.3. Forensics & Agrigenomics
        • 7.2.2.4. Reproductive Health
        • 7.2.2.5. HLA Typing
        • 7.2.2.6. Others
      • 7.2.3. Global DNA Sequencing by: Technology (Value)
        • 7.2.3.1. Third Generation DNA Sequencing
        • 7.2.3.2. Next-Generation Sequencing
        • 7.2.3.3. Sanger Sequencing
      • 7.2.4. Global DNA Sequencing by: End User (Value)
        • 7.2.4.1. Clinical Research
        • 7.2.4.2. Academic Research
        • 7.2.4.3. Biotechnology & Pharmaceutical Companies
        • 7.2.4.4. Hospitals & Clinics
        • 7.2.4.5. Others
      • 7.2.5. Global DNA Sequencing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. DNA Sequencing: by Type(USD Million)
  • Table 2. DNA Sequencing Instruments , by Region USD Million (2019-2024)
  • Table 3. DNA Sequencing Consumables , by Region USD Million (2019-2024)
  • Table 4. DNA Sequencing Services , by Region USD Million (2019-2024)
  • Table 5. DNA Sequencing: by Application(USD Million)
  • Table 6. DNA Sequencing Clinical Investigation , by Region USD Million (2019-2024)
  • Table 7. DNA Sequencing Oncology , by Region USD Million (2019-2024)
  • Table 8. DNA Sequencing Forensics & Agrigenomics , by Region USD Million (2019-2024)
  • Table 9. DNA Sequencing Reproductive Health , by Region USD Million (2019-2024)
  • Table 10. DNA Sequencing HLA Typing , by Region USD Million (2019-2024)
  • Table 11. DNA Sequencing Others , by Region USD Million (2019-2024)
  • Table 12. DNA Sequencing: by Technology(USD Million)
  • Table 13. DNA Sequencing Third Generation DNA Sequencing , by Region USD Million (2019-2024)
  • Table 14. DNA Sequencing Next-Generation Sequencing , by Region USD Million (2019-2024)
  • Table 15. DNA Sequencing Sanger Sequencing , by Region USD Million (2019-2024)
  • Table 16. DNA Sequencing: by End User(USD Million)
  • Table 17. DNA Sequencing Clinical Research , by Region USD Million (2019-2024)
  • Table 18. DNA Sequencing Academic Research , by Region USD Million (2019-2024)
  • Table 19. DNA Sequencing Biotechnology & Pharmaceutical Companies , by Region USD Million (2019-2024)
  • Table 20. DNA Sequencing Hospitals & Clinics , by Region USD Million (2019-2024)
  • Table 21. DNA Sequencing Others , by Region USD Million (2019-2024)
  • Table 22. South America DNA Sequencing, by Country USD Million (2019-2024)
  • Table 23. South America DNA Sequencing, by Type USD Million (2019-2024)
  • Table 24. South America DNA Sequencing, by Application USD Million (2019-2024)
  • Table 25. South America DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 26. South America DNA Sequencing, by End User USD Million (2019-2024)
  • Table 27. Brazil DNA Sequencing, by Type USD Million (2019-2024)
  • Table 28. Brazil DNA Sequencing, by Application USD Million (2019-2024)
  • Table 29. Brazil DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 30. Brazil DNA Sequencing, by End User USD Million (2019-2024)
  • Table 31. Argentina DNA Sequencing, by Type USD Million (2019-2024)
  • Table 32. Argentina DNA Sequencing, by Application USD Million (2019-2024)
  • Table 33. Argentina DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 34. Argentina DNA Sequencing, by End User USD Million (2019-2024)
  • Table 35. Rest of South America DNA Sequencing, by Type USD Million (2019-2024)
  • Table 36. Rest of South America DNA Sequencing, by Application USD Million (2019-2024)
  • Table 37. Rest of South America DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 38. Rest of South America DNA Sequencing, by End User USD Million (2019-2024)
  • Table 39. Asia Pacific DNA Sequencing, by Country USD Million (2019-2024)
  • Table 40. Asia Pacific DNA Sequencing, by Type USD Million (2019-2024)
  • Table 41. Asia Pacific DNA Sequencing, by Application USD Million (2019-2024)
  • Table 42. Asia Pacific DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 43. Asia Pacific DNA Sequencing, by End User USD Million (2019-2024)
  • Table 44. China DNA Sequencing, by Type USD Million (2019-2024)
  • Table 45. China DNA Sequencing, by Application USD Million (2019-2024)
  • Table 46. China DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 47. China DNA Sequencing, by End User USD Million (2019-2024)
  • Table 48. Japan DNA Sequencing, by Type USD Million (2019-2024)
  • Table 49. Japan DNA Sequencing, by Application USD Million (2019-2024)
  • Table 50. Japan DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 51. Japan DNA Sequencing, by End User USD Million (2019-2024)
  • Table 52. India DNA Sequencing, by Type USD Million (2019-2024)
  • Table 53. India DNA Sequencing, by Application USD Million (2019-2024)
  • Table 54. India DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 55. India DNA Sequencing, by End User USD Million (2019-2024)
  • Table 56. South Korea DNA Sequencing, by Type USD Million (2019-2024)
  • Table 57. South Korea DNA Sequencing, by Application USD Million (2019-2024)
  • Table 58. South Korea DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 59. South Korea DNA Sequencing, by End User USD Million (2019-2024)
  • Table 60. Taiwan DNA Sequencing, by Type USD Million (2019-2024)
  • Table 61. Taiwan DNA Sequencing, by Application USD Million (2019-2024)
  • Table 62. Taiwan DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 63. Taiwan DNA Sequencing, by End User USD Million (2019-2024)
  • Table 64. Australia DNA Sequencing, by Type USD Million (2019-2024)
  • Table 65. Australia DNA Sequencing, by Application USD Million (2019-2024)
  • Table 66. Australia DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 67. Australia DNA Sequencing, by End User USD Million (2019-2024)
  • Table 68. Rest of Asia-Pacific DNA Sequencing, by Type USD Million (2019-2024)
  • Table 69. Rest of Asia-Pacific DNA Sequencing, by Application USD Million (2019-2024)
  • Table 70. Rest of Asia-Pacific DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 71. Rest of Asia-Pacific DNA Sequencing, by End User USD Million (2019-2024)
  • Table 72. Europe DNA Sequencing, by Country USD Million (2019-2024)
  • Table 73. Europe DNA Sequencing, by Type USD Million (2019-2024)
  • Table 74. Europe DNA Sequencing, by Application USD Million (2019-2024)
  • Table 75. Europe DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 76. Europe DNA Sequencing, by End User USD Million (2019-2024)
  • Table 77. Germany DNA Sequencing, by Type USD Million (2019-2024)
  • Table 78. Germany DNA Sequencing, by Application USD Million (2019-2024)
  • Table 79. Germany DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 80. Germany DNA Sequencing, by End User USD Million (2019-2024)
  • Table 81. France DNA Sequencing, by Type USD Million (2019-2024)
  • Table 82. France DNA Sequencing, by Application USD Million (2019-2024)
  • Table 83. France DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 84. France DNA Sequencing, by End User USD Million (2019-2024)
  • Table 85. Italy DNA Sequencing, by Type USD Million (2019-2024)
  • Table 86. Italy DNA Sequencing, by Application USD Million (2019-2024)
  • Table 87. Italy DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 88. Italy DNA Sequencing, by End User USD Million (2019-2024)
  • Table 89. United Kingdom DNA Sequencing, by Type USD Million (2019-2024)
  • Table 90. United Kingdom DNA Sequencing, by Application USD Million (2019-2024)
  • Table 91. United Kingdom DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 92. United Kingdom DNA Sequencing, by End User USD Million (2019-2024)
  • Table 93. Netherlands DNA Sequencing, by Type USD Million (2019-2024)
  • Table 94. Netherlands DNA Sequencing, by Application USD Million (2019-2024)
  • Table 95. Netherlands DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 96. Netherlands DNA Sequencing, by End User USD Million (2019-2024)
  • Table 97. Rest of Europe DNA Sequencing, by Type USD Million (2019-2024)
  • Table 98. Rest of Europe DNA Sequencing, by Application USD Million (2019-2024)
  • Table 99. Rest of Europe DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 100. Rest of Europe DNA Sequencing, by End User USD Million (2019-2024)
  • Table 101. MEA DNA Sequencing, by Country USD Million (2019-2024)
  • Table 102. MEA DNA Sequencing, by Type USD Million (2019-2024)
  • Table 103. MEA DNA Sequencing, by Application USD Million (2019-2024)
  • Table 104. MEA DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 105. MEA DNA Sequencing, by End User USD Million (2019-2024)
  • Table 106. Middle East DNA Sequencing, by Type USD Million (2019-2024)
  • Table 107. Middle East DNA Sequencing, by Application USD Million (2019-2024)
  • Table 108. Middle East DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 109. Middle East DNA Sequencing, by End User USD Million (2019-2024)
  • Table 110. Africa DNA Sequencing, by Type USD Million (2019-2024)
  • Table 111. Africa DNA Sequencing, by Application USD Million (2019-2024)
  • Table 112. Africa DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 113. Africa DNA Sequencing, by End User USD Million (2019-2024)
  • Table 114. North America DNA Sequencing, by Country USD Million (2019-2024)
  • Table 115. North America DNA Sequencing, by Type USD Million (2019-2024)
  • Table 116. North America DNA Sequencing, by Application USD Million (2019-2024)
  • Table 117. North America DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 118. North America DNA Sequencing, by End User USD Million (2019-2024)
  • Table 119. United States DNA Sequencing, by Type USD Million (2019-2024)
  • Table 120. United States DNA Sequencing, by Application USD Million (2019-2024)
  • Table 121. United States DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 122. United States DNA Sequencing, by End User USD Million (2019-2024)
  • Table 123. Canada DNA Sequencing, by Type USD Million (2019-2024)
  • Table 124. Canada DNA Sequencing, by Application USD Million (2019-2024)
  • Table 125. Canada DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 126. Canada DNA Sequencing, by End User USD Million (2019-2024)
  • Table 127. Mexico DNA Sequencing, by Type USD Million (2019-2024)
  • Table 128. Mexico DNA Sequencing, by Application USD Million (2019-2024)
  • Table 129. Mexico DNA Sequencing, by Technology USD Million (2019-2024)
  • Table 130. Mexico DNA Sequencing, by End User USD Million (2019-2024)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. DNA Sequencing: by Type(USD Million)
  • Table 143. DNA Sequencing Instruments , by Region USD Million (2027-2032)
  • Table 144. DNA Sequencing Consumables , by Region USD Million (2027-2032)
  • Table 145. DNA Sequencing Services , by Region USD Million (2027-2032)
  • Table 146. DNA Sequencing: by Application(USD Million)
  • Table 147. DNA Sequencing Clinical Investigation , by Region USD Million (2027-2032)
  • Table 148. DNA Sequencing Oncology , by Region USD Million (2027-2032)
  • Table 149. DNA Sequencing Forensics & Agrigenomics , by Region USD Million (2027-2032)
  • Table 150. DNA Sequencing Reproductive Health , by Region USD Million (2027-2032)
  • Table 151. DNA Sequencing HLA Typing , by Region USD Million (2027-2032)
  • Table 152. DNA Sequencing Others , by Region USD Million (2027-2032)
  • Table 153. DNA Sequencing: by Technology(USD Million)
  • Table 154. DNA Sequencing Third Generation DNA Sequencing , by Region USD Million (2027-2032)
  • Table 155. DNA Sequencing Next-Generation Sequencing , by Region USD Million (2027-2032)
  • Table 156. DNA Sequencing Sanger Sequencing , by Region USD Million (2027-2032)
  • Table 157. DNA Sequencing: by End User(USD Million)
  • Table 158. DNA Sequencing Clinical Research , by Region USD Million (2027-2032)
  • Table 159. DNA Sequencing Academic Research , by Region USD Million (2027-2032)
  • Table 160. DNA Sequencing Biotechnology & Pharmaceutical Companies , by Region USD Million (2027-2032)
  • Table 161. DNA Sequencing Hospitals & Clinics , by Region USD Million (2027-2032)
  • Table 162. DNA Sequencing Others , by Region USD Million (2027-2032)
  • Table 163. South America DNA Sequencing, by Country USD Million (2027-2032)
  • Table 164. South America DNA Sequencing, by Type USD Million (2027-2032)
  • Table 165. South America DNA Sequencing, by Application USD Million (2027-2032)
  • Table 166. South America DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 167. South America DNA Sequencing, by End User USD Million (2027-2032)
  • Table 168. Brazil DNA Sequencing, by Type USD Million (2027-2032)
  • Table 169. Brazil DNA Sequencing, by Application USD Million (2027-2032)
  • Table 170. Brazil DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 171. Brazil DNA Sequencing, by End User USD Million (2027-2032)
  • Table 172. Argentina DNA Sequencing, by Type USD Million (2027-2032)
  • Table 173. Argentina DNA Sequencing, by Application USD Million (2027-2032)
  • Table 174. Argentina DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 175. Argentina DNA Sequencing, by End User USD Million (2027-2032)
  • Table 176. Rest of South America DNA Sequencing, by Type USD Million (2027-2032)
  • Table 177. Rest of South America DNA Sequencing, by Application USD Million (2027-2032)
  • Table 178. Rest of South America DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 179. Rest of South America DNA Sequencing, by End User USD Million (2027-2032)
  • Table 180. Asia Pacific DNA Sequencing, by Country USD Million (2027-2032)
  • Table 181. Asia Pacific DNA Sequencing, by Type USD Million (2027-2032)
  • Table 182. Asia Pacific DNA Sequencing, by Application USD Million (2027-2032)
  • Table 183. Asia Pacific DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 184. Asia Pacific DNA Sequencing, by End User USD Million (2027-2032)
  • Table 185. China DNA Sequencing, by Type USD Million (2027-2032)
  • Table 186. China DNA Sequencing, by Application USD Million (2027-2032)
  • Table 187. China DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 188. China DNA Sequencing, by End User USD Million (2027-2032)
  • Table 189. Japan DNA Sequencing, by Type USD Million (2027-2032)
  • Table 190. Japan DNA Sequencing, by Application USD Million (2027-2032)
  • Table 191. Japan DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 192. Japan DNA Sequencing, by End User USD Million (2027-2032)
  • Table 193. India DNA Sequencing, by Type USD Million (2027-2032)
  • Table 194. India DNA Sequencing, by Application USD Million (2027-2032)
  • Table 195. India DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 196. India DNA Sequencing, by End User USD Million (2027-2032)
  • Table 197. South Korea DNA Sequencing, by Type USD Million (2027-2032)
  • Table 198. South Korea DNA Sequencing, by Application USD Million (2027-2032)
  • Table 199. South Korea DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 200. South Korea DNA Sequencing, by End User USD Million (2027-2032)
  • Table 201. Taiwan DNA Sequencing, by Type USD Million (2027-2032)
  • Table 202. Taiwan DNA Sequencing, by Application USD Million (2027-2032)
  • Table 203. Taiwan DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 204. Taiwan DNA Sequencing, by End User USD Million (2027-2032)
  • Table 205. Australia DNA Sequencing, by Type USD Million (2027-2032)
  • Table 206. Australia DNA Sequencing, by Application USD Million (2027-2032)
  • Table 207. Australia DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 208. Australia DNA Sequencing, by End User USD Million (2027-2032)
  • Table 209. Rest of Asia-Pacific DNA Sequencing, by Type USD Million (2027-2032)
  • Table 210. Rest of Asia-Pacific DNA Sequencing, by Application USD Million (2027-2032)
  • Table 211. Rest of Asia-Pacific DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 212. Rest of Asia-Pacific DNA Sequencing, by End User USD Million (2027-2032)
  • Table 213. Europe DNA Sequencing, by Country USD Million (2027-2032)
  • Table 214. Europe DNA Sequencing, by Type USD Million (2027-2032)
  • Table 215. Europe DNA Sequencing, by Application USD Million (2027-2032)
  • Table 216. Europe DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 217. Europe DNA Sequencing, by End User USD Million (2027-2032)
  • Table 218. Germany DNA Sequencing, by Type USD Million (2027-2032)
  • Table 219. Germany DNA Sequencing, by Application USD Million (2027-2032)
  • Table 220. Germany DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 221. Germany DNA Sequencing, by End User USD Million (2027-2032)
  • Table 222. France DNA Sequencing, by Type USD Million (2027-2032)
  • Table 223. France DNA Sequencing, by Application USD Million (2027-2032)
  • Table 224. France DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 225. France DNA Sequencing, by End User USD Million (2027-2032)
  • Table 226. Italy DNA Sequencing, by Type USD Million (2027-2032)
  • Table 227. Italy DNA Sequencing, by Application USD Million (2027-2032)
  • Table 228. Italy DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 229. Italy DNA Sequencing, by End User USD Million (2027-2032)
  • Table 230. United Kingdom DNA Sequencing, by Type USD Million (2027-2032)
  • Table 231. United Kingdom DNA Sequencing, by Application USD Million (2027-2032)
  • Table 232. United Kingdom DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 233. United Kingdom DNA Sequencing, by End User USD Million (2027-2032)
  • Table 234. Netherlands DNA Sequencing, by Type USD Million (2027-2032)
  • Table 235. Netherlands DNA Sequencing, by Application USD Million (2027-2032)
  • Table 236. Netherlands DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 237. Netherlands DNA Sequencing, by End User USD Million (2027-2032)
  • Table 238. Rest of Europe DNA Sequencing, by Type USD Million (2027-2032)
  • Table 239. Rest of Europe DNA Sequencing, by Application USD Million (2027-2032)
  • Table 240. Rest of Europe DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 241. Rest of Europe DNA Sequencing, by End User USD Million (2027-2032)
  • Table 242. MEA DNA Sequencing, by Country USD Million (2027-2032)
  • Table 243. MEA DNA Sequencing, by Type USD Million (2027-2032)
  • Table 244. MEA DNA Sequencing, by Application USD Million (2027-2032)
  • Table 245. MEA DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 246. MEA DNA Sequencing, by End User USD Million (2027-2032)
  • Table 247. Middle East DNA Sequencing, by Type USD Million (2027-2032)
  • Table 248. Middle East DNA Sequencing, by Application USD Million (2027-2032)
  • Table 249. Middle East DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 250. Middle East DNA Sequencing, by End User USD Million (2027-2032)
  • Table 251. Africa DNA Sequencing, by Type USD Million (2027-2032)
  • Table 252. Africa DNA Sequencing, by Application USD Million (2027-2032)
  • Table 253. Africa DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 254. Africa DNA Sequencing, by End User USD Million (2027-2032)
  • Table 255. North America DNA Sequencing, by Country USD Million (2027-2032)
  • Table 256. North America DNA Sequencing, by Type USD Million (2027-2032)
  • Table 257. North America DNA Sequencing, by Application USD Million (2027-2032)
  • Table 258. North America DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 259. North America DNA Sequencing, by End User USD Million (2027-2032)
  • Table 260. United States DNA Sequencing, by Type USD Million (2027-2032)
  • Table 261. United States DNA Sequencing, by Application USD Million (2027-2032)
  • Table 262. United States DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 263. United States DNA Sequencing, by End User USD Million (2027-2032)
  • Table 264. Canada DNA Sequencing, by Type USD Million (2027-2032)
  • Table 265. Canada DNA Sequencing, by Application USD Million (2027-2032)
  • Table 266. Canada DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 267. Canada DNA Sequencing, by End User USD Million (2027-2032)
  • Table 268. Mexico DNA Sequencing, by Type USD Million (2027-2032)
  • Table 269. Mexico DNA Sequencing, by Application USD Million (2027-2032)
  • Table 270. Mexico DNA Sequencing, by Technology USD Million (2027-2032)
  • Table 271. Mexico DNA Sequencing, by End User USD Million (2027-2032)
  • Table 272. Research Programs/Design for This Report
  • Table 273. Key Data Information from Secondary Sources
  • Table 274. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global DNA Sequencing: by Type USD Million (2019-2024)
  • Figure 5. Global DNA Sequencing: by Application USD Million (2019-2024)
  • Figure 6. Global DNA Sequencing: by Technology USD Million (2019-2024)
  • Figure 7. Global DNA Sequencing: by End User USD Million (2019-2024)
  • Figure 8. South America DNA Sequencing Share (%), by Country
  • Figure 9. Asia Pacific DNA Sequencing Share (%), by Country
  • Figure 10. Europe DNA Sequencing Share (%), by Country
  • Figure 11. MEA DNA Sequencing Share (%), by Country
  • Figure 12. North America DNA Sequencing Share (%), by Country
  • Figure 13. Global DNA Sequencing share by Players 2024 (%)
  • Figure 14. Global DNA Sequencing share by Players (Top 3) 2024(%)
  • Figure 15. Global DNA Sequencing share by Players (Top 5) 2024(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Siemens AG (Germany) Revenue: by Geography 2024
  • Figure 19. Pacific Biosciences of California, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Pacific Biosciences of California, Inc. (United States) Revenue: by Geography 2024
  • Figure 21. Eppendorf (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Eppendorf (Germany) Revenue: by Geography 2024
  • Figure 23. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. PerkinElmer, Inc. (United States) Revenue: by Geography 2024
  • Figure 25. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Agilent Technologies, Inc. (United States) Revenue: by Geography 2024
  • Figure 27. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Illumina, Inc. (United States) Revenue: by Geography 2024
  • Figure 29. LI-COR Biosciences, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 30. LI-COR Biosciences, Inc (United States) Revenue: by Geography 2024
  • Figure 31. Oxford Nanopore Technologies Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Oxford Nanopore Technologies Limited (United Kingdom) Revenue: by Geography 2024
  • Figure 33. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2024
  • Figure 35. ThermoFisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 36. ThermoFisher Scientific (United States) Revenue: by Geography 2024
  • Figure 37. Longas Technologies (Australia) Revenue, Net Income and Gross profit
  • Figure 38. Longas Technologies (Australia) Revenue: by Geography 2024
  • Figure 39. Global DNA Sequencing: by Type USD Million (2027-2032)
  • Figure 40. Global DNA Sequencing: by Application USD Million (2027-2032)
  • Figure 41. Global DNA Sequencing: by Technology USD Million (2027-2032)
  • Figure 42. Global DNA Sequencing: by End User USD Million (2027-2032)
  • Figure 43. South America DNA Sequencing Share (%), by Country
  • Figure 44. Asia Pacific DNA Sequencing Share (%), by Country
  • Figure 45. Europe DNA Sequencing Share (%), by Country
  • Figure 46. MEA DNA Sequencing Share (%), by Country
  • Figure 47. North America DNA Sequencing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Siemens AG (Germany)
  • Pacific Biosciences of California, Inc. (United States)
  • Eppendorf (Germany)
  • PerkinElmer, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • Illumina, Inc. (United States)
  • LI-COR Biosciences, Inc (United States)
  • Oxford Nanopore Technologies Limited (United Kingdom)
  • F. Hoffmann-La Roche AG (Switzerland)
  • ThermoFisher Scientific (United States)
  • Longas Technologies (Australia)
Additional players considered in the study are as follows:
QIAGEN (Germany) , Macrogen, Inc. (South Korea) , Bio-Rad Laboratories, Inc. (United States) , Myriad Genetics (United States)
Select User Access Type

Key Highlights of Report


Feb 2025 215 Pages 52 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global DNA Sequencing Quantitative research analysis
Global DNA Sequencing Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Siemens AG (Germany), Pacific Biosciences of California, Inc. (United States), Eppendorf (Germany), PerkinElmer, Inc. (United States), Agilent Technologies, Inc. (United States), Illumina, Inc. (United States), LI-COR Biosciences, Inc (United States), Oxford Nanopore Technologies Limited (United Kingdom), F. Hoffmann-La Roche AG (Switzerland), ThermoFisher Scientific (United States) and Longas Technologies (Australia) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising demand for precision medicine" is seen as one of major influencing trends for DNA Sequencing Market during projected period 2024-2032.
The DNA Sequencing market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global DNA Sequencing Report?

Have a Query? Click Here

Other Related Reports

Agriculture Biotechnology Comprehensive Study by Type (Genome Editing Tools, Deoxy Ribonucleic Acid Sequencing, Ribonucleic Acid Interference, Synthetic Biology, Biochips), Application (Herbicide Tol...
$ 3800
Specific Pathogen Free Comprehensive Study by End Users (Research Institutes, Pharmaceutical Companies), Distribution Channels (Company Outlets, E-commerce Websites, Hypermarkets and Supermarkets, Po...
$ 3450
Polymers Drug Delivery Comprehensive Study by Type (Micelles, Microgels, Dendrimer, Hydrogels, Others), Application (Hospitals, Medical Research Center, Pharmaceutical Factory, Others), Formulations ...
$ 3650
Plant Activators Comprehensive Study by Type (Biological Plant Activators, Chemical Plant Activators), Application (Foliar Spray, Soil Treatment, Others), Forms (Solutions, Water-Dispersible & Water-...
$ 3450
Epithelial Stem Cells Comprehensive Study by Type (Absorptive Cells, Goblet Cell, Paneth Cells, Oligodendrocytes), Application (Tissue Repair Damage, Autoimmune Diseases, Others) Players and Region -...
$ 3500
Microbial Inoculants Comprehensive Study by Type (Agricultural Inoculants, Silage Inoculants), Crop Type (Oilseeds & Pulses, Cereals & Grains, Fruits & Vegetables, Forage), Microbes (Bacterial, Funga...
$ 3500